基于机器学习的监督模型用于预测血糖升高的情况.
Marwa Mustafa Owess1,2, Amani Yousef Owda1, Majdi Owda3
1Department of Natural, Engineering, and Technology Sciences, Arab American University, Ramallah P600, Palestine.
概括
机器学习模型准确地预测血糖升高,这是糖尿病前期和糖尿病的关键指标. 随机森林模型达到98.4%的准确性,有助于对这种不断增长的非传染性疾病的早期检测和干预.
科学领域:
- 医疗信息学 医疗信息学
- 公共卫生 公共卫生
- 机器学习 机器学习
背景情况:
- 血糖升高 (高血糖) 是糖尿病前期和糖尿病的重要指标,这是一个普遍存在的非传染性疾病 (NCD),其全球发病率正在上升.
- 早期发现糖尿病对于预防严重的健康并发症至关重要,但大规模的查计划面临成本和资源挑战.
- 糖尿病的患病率不断上升,特别是在发展中国家,需要创新和高效的检测方法.
研究的目的:
- 开发和评估监督机器学习模型,用于早期检测和预测血糖升高.
- 为了确定模型开发的主要糖尿病风险因素,包括年龄,BMI,生活方式和现有条件.
- 为了比较各种分类算法在预测高血糖的性能.
主要方法:
- 利用了来自STEPwise方法的数据集,对巴勒斯坦社区的NCD风险因素研究进行了研究,重点是成人.
- 使用监督机器学习算法:随机森林,决策树,Adaboost,XGBoost,袋装决策树和多层感知器 (MLP).
- 输入特征包括糖尿病相关的风险因素,如年龄,BMI,饮食习惯,体力活动,其他疾病和禁食血糖.
主要成果:
- 随机森林分类器在预测血糖升高时达到最高准确率98.4%.
- 包装决策树,XGBoost,MLP,AdaBoost和决策树模型也表现出高性能,准确度在94.8%至97.4%之间.
- 这些模型有效地利用糖尿病风险因素进行准确的预测,突出了数据驱动查的潜力.
结论:
- 监督机器学习模型,特别是随机森林,为检测和预测血糖升高提供了高度准确和高效的方法.
- 这些模型可以支持早期识别患有糖尿病前期和糖尿病风险的个体,促进及时干预.
- 这些发现表明,机器学习在增强糖尿病查策略方面发挥着有希望的作用,特别是在资源有限的环境中.
相关概念视频
01:22Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
01:15Hypoglycemia and Glucagon
229
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
229
01:22Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
186
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
186
01:16Hormones Regulating Blood Glucose
3.2K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.2K